Michael Stephens is an addiction treatment content specialist focused on opioid use disorder (OUD), medication-assisted treatment (MAT), and telemedicine-based care delivery. His work is grounded in current clinical standards and evidence-based practices, including the use of buprenorphine/naloxone (Suboxone) for the treatment of opioid dependence.
Michael collaborates with healthcare professionals and addiction treatment programs to ensure accuracy, relevance, and alignment with real-world clinical workflows. His writing focuses on patient education, treatment access, withdrawal management, and long-term recovery strategies—particularly for underserved and rural populations across Tennessee.
All content authored by Michael Stephens is reviewed to reflect current treatment guidelines and regulatory considerations, with an emphasis on clarity, medical accuracy, and patient safety.
